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Oxygen is a crucial molecule for cellular function. When oxygen demand exceeds supply, the oxygen sensing
pathway centred on the hypoxia inducible factor (HIF) is switched on and promotes adaptation to hypoxia by up-
regulating genes involved in angiogenesis, erythropoiesis and glycolysis. The regulation of HIF is tightly modulated
through intricate regulatory mechanisms. Notably, its protein stability is controlled by the oxygen sensing prolyl
hydroxylase domain (PHD) enzymes and its transcriptional activity is controlled by the asparaginyl hydroxylase FIH
(factor inhibiting HIF-1).
To probe the complexity of hypoxia-induced HIF signalling, efforts in mathematical modelling of the pathway have
been underway for around a decade. In this paper, we review the existing mathematical models developed to
describe and explain specific behaviours of the HIF pathway and how they have contributed new insights into our
understanding of the network. Topics for modelling included the switch-like response to decreased oxygen
gradient, the role of micro environmental factors, the regulation by FIH and the temporal dynamics of the HIF
response. We will also discuss the technical aspects, extent and limitations of these models. Recently, HIF pathway
has been implicated in other disease contexts such as hypoxic inflammation and cancer through crosstalking with
pathways like NFκB and mTOR. We will examine how future mathematical modelling and simulation of interlinked
networks can aid in understanding HIF behaviour in complex pathophysiological situations. Ultimately this would
allow the identification of new pharmacological targets in different disease settings.
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Hypoxia is the cellular stress which occurs when oxygen
demand exceeds supply. As a homeostatic response to this
challenge, several classes of genes are up-regulated, which
encode for proteins involved in angiogenesis, erythropoiesis
and glycolysis, such as vascular endothelial growth factor,
erythropoietin, most of the glycolytic enzymes and glucose
transporters [1]. The possibility that higher organisms have
direct oxygen sensing mechanisms, like those known for
yeast and bacteria, has always interested biologists. A
major advance in the knowledge of mammalian
oxygen regulation came from studies on the hypoxic
induction of erythropoietin (EPO). This glycoprotein
regulates mammalian erythrocyte production and, as a
result, oxygen delivery to tissues. EPO mRNA levels
are several hundred folds induced in rodent liver and
kidney in response to hypoxia and this induction was* Correspondence: alex.cheong@ucd.ie
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reproduction in any medium, provided the orfound to be effected by a nuclear factor induced by
hypoxia, named hypoxia inducible factor (HIF) [2,3].
Later it was found that HIF is a dimer composed of
an oxygen-regulated alpha subunit (HIF-1α, -2α and -3α)
and a constitutively expressed nuclear beta subunit
(HIF-1β, -2β and -3β) [4,5]. Although all the subunits
are involved in generating the diversity of the transcrip-
tional response to hypoxia [6], the core components are the
1α and 1β subunits.
In normoxia, the HIF-α protein levels are low due to
constant ubiquitination-dependent degradation via the
Von Hippel-Landau (VHL) E3 ligase protein [7], which
recognises proline hydroxylated (Pro-OH) HIFα [8-10]
on two independent sites: a carboxyl terminal and an
amino terminal oxygen-dependent degradation domains
(CODDD and NODDD, respectively) [11,12]. These
hydroxylation reactions are catalysed by oxygen-sensitive
prolyl hydroxylases (PHD) [13,14], establishing hydroxyl-
ation as a novel functional post-translational modificationl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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http://www.biosignaling.com/content/11/1/42in signalling pathways [11]. Another level of control lies
with the oxygen-sensitive asparaginyl hydroxylase FIH
(factor inhibiting HIF), which hydroxylates the HIF
alpha-protein and inhibits subsequent recruitment of
the transcriptional co-activators p300 and CBP [15-18],
thereby inhibiting the HIF transcriptional activity. In hyp-
oxia, when less oxygen is available for PHD/FIH-mediated
hydroxylation, HIF-α protein accumulates, translocates into
the nucleus, associates with HIF-β and the co-activators
p300/CBP to induce gene expression by binding to the
conserved [A/G]CGTG hypoxia-responsive element (HRE)
[1], including PHD2 [19] and PHD3 [20], establishing a
negative feedback loop. A historical timeline of the major
experimental findings together with the core components
of the HIF network are shown in Figure 1. The ancient HIF
response is conserved throughout the metazoans [21] andVHL recognises Pro-OH HIF  [8-10]
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Figure 1 Experimental and modelling advances in the HIF pathway. (
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conditions of low cellular oxygen, such as high altitude,
ischemic stroke or myocardial infarction [1,11]. However, it
can be hijacked in patho-physiological conditions such as
cancer, where it allows for clonal selection of cancerous
cells adapted to the hypoxic tumour microenvironment [1].
HIF-α is thus a promising anticancer drug target, and
several compounds targeting HIF translation, degradation
or transcriptional activity have already been approved [22].
In a linear biochemical cascade, effects of perturbations
such as pharmacological inhibition of cascade components
can be intuitively predicted and interpreted. However,
cellular responses often appear to be mediated through
highly interconnected and complex networks forming from
multiple pathways crosstalk and feedback regulation. Such
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to the references. (B) Core elements of the HIF pathway: in normoxia,
lows the binding of von Hippel–Lindau protein (VHL), eventually
FIH, which interferes with the interaction with transcriptional
upply, the oxygen-sensitive PHD and FIH enzymes are inhibited. Thus
β and p300/CBP, leading to formation of a transcriptional complex
genes. One such gene upregulated encodes for PHD, which creates a
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http://www.biosignaling.com/content/11/1/42HIF signalling network has motivated studies in which
mathematical models are used to gain understanding of the
emergent network behaviours. The focus of this review is
to bring together the modelling efforts and discuss the
models developed so far for the HIF signalling pathway.
These models, implemented to run as computer programs,
can generate simulations which provides a powerful tool to
analyse and understand the HIF network behaviour in
complex physiological situations, including inflammation
and cancer. Moreover, model-based analysis would
allow the identification of new pharmacological targets in
different disease settings. We hope a comprehensive review
of the available models of the HIF pathway will help lay a
foundation for the development of more complete HIF
models, as well as of future large-scale models integrating
HIF and other pathways.
Mathematical models of the HIF pathway
Overview of the HIF pathway models
Mathematical modelling of the HIF pathway was initiated
by Kohn and colleagues [23], who also pioneered the
development of molecular interaction map (MIM). Since
then, a number of HIF models have been developed
focusing largely on four topics which we will discuss in
detail: (1) oxygen-mediated switch-like behaviour of HIF
nuclear accumulation and transcriptional activity [23-27];
(2) HIF sensitivity to the molecular micro environment
[25,28]; (3) role of FIH in the modulation of HIF activity
and stability response [27,29-31] and (4) temporal dynamics
of the HIF response to hypoxia [23,25-28,30,31]. A timeline
of these models is given in Figure 1A.
Modelling of a biochemical network typically begins
with construction of a molecular interactions map which
summarises the biological knowledge and provides a
comprehensible and unambiguous graphical description
of the network regulation. Figure 2 provides an example
of such an interaction map for the HIF network [31].
The interactions are then formulated using precise
mathematical terms which make up the mathematical
model of the network. The available HIF models are
primarily developed using ordinary differential equations
(ODE) which are based on biochemical reaction kinetics,
an approach appropriate for addressing network dynamic
behaviours. Reaction kinetics described by either mass
action or Michaelis-Menten laws are used to formulate the
ODEs for each component of the network interaction map.
In some models, model reduction using quasi-steady state
analysis was performed for certain reactions, such as the
hydroxylation reactions mediated by PHD and FIH and the
interaction between VHL and prolyl-hydroxylated HIF
protein. By using the Briggs-Haldane approximation [29],
intermediary states can be assumed time invariant and
neglected, thereby reducing the complexity of the system.
Furthermore, values for the initial concentrations of eachvariable species and kinetic rate constants (e.g. association,
dissociation, catalytics, synthesis, degradation) are either
obtained from experimental measurements (in-house or
from the literature) or estimated by numerically searching
the parameter space for optimal fitting. A detailed
summary of the more technical aspects of each of the
developed mathematical models for the HIF pathway
is presented in Table 1.
Switch-like behaviour in response to decreasing oxygen
While the HIF-α response is experimentally reported to
increase exponentially with reducing oxygen tension over
the physiological range, there is instead a slight decrease in
the HIF-α response at low oxygen levels (0.5% to 0% O2)
[32]. This decrease is intriguing because the hydroxylation
reaction by PHD requires oxygen as substrate and it is
generally assumed that at levels close to anoxia, the HIF
response is maximal. These observations gave rise to the
hypothesis that HIF response could offer an on/off
(a “switch”) mechanism for the onset of hypoxia-induced
gene expression and that there is a sustained plateau of
HIF response at very low oxygen tension [23,25-27,33].
Many of the available HIF models aim to theoretically
explain this hypothetical switching mechanism, and at
least three conceptually different explanations have been
provided (Figure 3).
Starting from a comprehensive MIM of the HIF network,
Kohn and colleagues reduce it to a core subsystem
comprising of HIF-α, HIF-β, PHD2, PHD3, VHL and a
generic HIF target gene containing a hypoxia responsive
element [23]. Under normal oxygen conditions, the
oxygen-independent synthesis rate of HIF-α is assumed to
be lower than the oxygen-dependent degradation rate
arising from a fast hydroxylation reaction by the PHD
enzymes. Thus almost every HIF protein synthesised
would be hydroxylated and degraded before being able
to bind HIF-β. As the level of oxygen concentration
decreases, PHD activity is increasingly reduced, resulting in
decreasing HIF-α degradation rate which at a threshold of
oxygen level, becomes lower than the HIF-α synthesis rate.
Subsequently, accumulated HIF-α associates with HIF-β,
leading to HRE occupancy. Kohn’s model manages to
simulate a sharp increase in HIF response and a plateau
phase at low oxygen tension. Interestingly, the model
analysis proposes that this sigmoidal, switch-like behaviour
occurs only if the affinity of HIF-α for PHD is
assumed greater than for HIF-β [23]. The switch is
further investigated by Yu and collaborators using a
Boolean based extreme pathway analysis approach
[26]. In Yu’s model, the HIF network is further simplified
by excluding reactions which are shown not to be required
for the switch-like behaviour, such as the PHD negative
feedback loop [23]. In addition, Yu’s model considers 3
major pathways for HIF degradation [26]. This modified
Figure 2 Molecular interaction map (MIM) for the HIF network. An example of the MIM used by our group for modelling the HIF response.
The cellular localisation of the various moieties of HIF (free HIF, prolyl-hydroxylated pOH and asparaginyl-hydroxylated aOH), VHL, PHD and FIH
are described to be either cytoplasmic or nuclear. Model reactions are numbered in red. Output of the MIM is the Gaussia luciferase signal under
the control of HRE. Figure is reproduced from [31] with permission.
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http://www.biosignaling.com/content/11/1/42model predicts that the switch-like behaviour is
caused by switching from a PHD-O2-VHL-dependent
HIF degradation pathway in normoxia to an oxygen-
independent pathway in hypoxia. The latter may be due to
the reported binding of p53 to HIF in anoxia (<0.2% O2)
which leads to induction of HIF degradation [34].
Although the models by Kohn et al and Yu et al both
describe a plateau in the HIF response at very low
oxygen tension, this is however not in total agreement
with the experimental data they have used, which shows
instead an attenuation of the HIF response at oxygen
levels close to anoxia [32]. In order to address this
discrepancy, Kooner and colleagues have extended Kohn’s
model by considering the role of oxygen in mediating the
reactions of HIF-α with PHD, HIF-β and HRE, as well as
its nuclear export [33]. Their model assumes that HIF-α
and PHD associate in an oxygen-dependent manner
but the dissociation reaction is oxygen-independent.
Furthermore, HIF-α: HRE and HIF-1α: HIF-1β disso-
ciations as well as HIF-α nuclear export are assumed
to be linearly dependent on oxygen concentration.
Using data on the export of HIF-α from the nucleus
and its degradation in the cytoplasm following
reoxygenation [35,36], Kooner’s model is able to
reproduce the attenuation effect of the HIF response
at oxygen concentrations below 0.5%. This suggests
that the localisation of HIF and other core proteins
can be significantly important for the modulation of
the HIF response.Importance of the molecular microenvironment
In addition to oxygen, the hydroxylation reaction catalysed
by PHD requires both Fe2+ and 2-oxoglutarate (2OG, also
known as α-ketoglutarate) as reactants [11]. The reaction
can also be affected by other micro environmental factors,
including ascorbate (vitamin C). Their levels vary across
tissues, which may affect the tissue-specific HIF response
via the regulation of PHD activity [37]. Furthermore, 2OG
is converted to succinate (Figure 4A), both of which are
part of the Kreb’s cycle, and directly link PHD activity to
cell metabolism [38,39].
To analyse the effect of the molecular environment on
the HIF response, Qutub and Popel constructed a model
of the HIF network incorporating the levels of Fe2+,
ascorbate and 2OG [25]. When the cellular levels of
PHD, 2OG and Fe2+ are in excess, their model predicts a
steep drop in HIF hydroxylation with decreased
oxygen. However, if any one of the reactants is limiting, a
near-linear response to oxygen is observed instead.
Moreover, when two or more reactants are limiting,
HIF-α hydroxylation is greatly reduced with a significant
decrease in sensitivity to oxygen (Figure 4B). The
effect of ascorbate is found to be more complex, and
an intermediate response is instead predicted when
ascorbate level is limiting [25]. These predictions open up
potential therapeutic strategies for modulating HIF-α
hydroxylation by varying the metabolic environment of
cells. A later model [28] includes the level of succinate,
which has been shown to negatively feedback onto the
Table 1 Summary of the main features of HIF models
Model
reference
Modelled behaviour Major assumptions Findings/Predictions Modelling approach Parameter finding
Kohn et al.,
2004
HRE occupancy and/
or mRNA expression in
response to changes
in oxygen concentration.
(1) Essential network behaviour
(e.g. switch-like behaviour)
encoded in core subsystem;
A switch-like behaviour for HIF is
predicted to originate from
HIFα protein stabilisation and
activity are modelled by
numerically integrating a
system of ODEs at each
oxygen concentration.
k-space for optimised
sharpness of HRE occupancy
in response to oxygen
concentration changes.
(2) PHD confers oxygen dependence; (i) rapid oxygen-independent
HIFα synthesis
(3) Only one PHD isoform is
dominant in each cell line;
(ii) oxygen-dependent HIFα
degradation
(4) HIFα refers to either HIF-1α or HIF2α (iii) a higher affinity of HIFα for
PHD than HIF-1β
(5) Hypoxia responsive genes are
activated by HIFα binding to HRE;
The negative feedback loop (HIF: PHD2)
has non influence on this behaviour
(6) Hydroxylated moieties are equally
likely to bind to and activate HRE;
(7) PHD promoter contains a HRE, which
creates a negative feedback loop;
(8) HIFα is synthesized at a constant rate;
(9) HIF-1β concentration is constant.
Kooner et al.,
2006
HRE occupancy and/or
mRNA expression in
response to changes in
oxygen concentration.
In comparison to Kohn’s model: Oxygen-dependence of HIF-α: HIF-1β and
HIF-α: HIF-1β: HRE complexes dissociation
and HIF-α nuclear export is proposed to
be the major mechanism responsible for
the decrease in HIF protein and activity in
the 0-0.5% oxygen tension.
HIFα protein stabilisation and
activity are modelled by
numerically integrating a
system of ODEs at each
oxygen concentration.
Experimental or assumption
based mostly on NFκB model
(e.g. mRNA and protein
synthesis and degradation).
(1) HIF dissociation from HIF-α: HIF-1β
and HIF-α: HIF-1β: HRE complexes and
nuclear export* is linearly dependent
on oxygen;
(2) HIF-α and PHD associate in an
oxygen-dependent way but the
dissociation is oxygen-independent;
(3) Hydroxylation and ubiquination can
occur both in the nucleus and cytosol;
(4) Negative feedback via PHD is not
necessary.
Yu et al., 2007 HRE occupancy and/or
mRNA expression in
response to changes in
oxygen concentration
(1) Identification of the major pathways
responsible for a behaviour can be
analytically identified by extreme
pathway analysis (EPA) instead of the
more computationally-demanding
numerical integration of a system of ODEs;
Switch-like behaviour is predicted to
originate from the switching of a
PHD-O2-VHL-dependent HIF degradation
pathway in normoxia to an oxygen-
independent degradation pathway
in hypoxia.
Extreme pathway analysis for the
analytical identification of key
components responsible for
the sharpness of the HIF
response to oxygen, followed
by analysis of fluxes through
the pathway.
k-sets from Kohn et al. (2004).
(2) Negative feedback via PHD is
not included;
(3) HIF-α precursor species is a constant
and therefore is integrated in the HIF
synthesis rate constant.
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Table 1 Summary of the main features of HIF models (Continued)
Qutub and
Popel, 2006
Sensitivity of HIF protein
to hydroxylation
cofactors and PHD
Ascorbate is the key reducing agent
responsible for keeping the Fe2+ pool
in the cell, counteracting the oxidizing
role of H2O2.
Two HIF responses to hypoxia are
predicted according to the
concentrations of PHD, Fe2+ and 2OG,
which can reflect different cellular/
environmental contexts. These 2
responses are either a steep switch-like
response when all hydroxylation
reactants are in excess, or a gradual
increase, with a near-linear oxygen
sensitivity when the reactants are
limiting.
HIF protein levels are modelled
by numerically integrating a
system of ODE at each O2 level
with different concentrations of
key cofactors of the PHD
hydroxylation reaction
Experimental or estimated
from the model followed
sensitivity analysis.
Qutub and
Popel, 2007
Temporal effect on HIF
protein stabilisation by
succinate inhibition and
PHD negative feedback.
This model builds on the one from Qutub
and Popel (2006) and includes the effect
of succinate, a product of the PHD
hydroxylation reaction, on the ratio
of PHD2 to HIF protein.
The ratio of PHD2 to HIF in different
tissues and cell types is proposed to
modulate the HIF accumulation to
chronic hypoxia.
In addition to the approach in
Qutub and Popel (2006), the
model integrates the time course
for PHD2 synthesised in response
to hypoxia and the accumulation
of succinate.
Experimental or estimated
from the model followed
sensitivity analysis.
The model predicts a very sharp and
transient accumulation of unhydroxylated
HIF protein at high PHD2: HIF ratio, and a
reduced but sustained HIF stabilisation at
low PHD2: HIF ratios.
Accumulation of succinate under
conditions of chronic hypoxia is
predicted to inhibit the HIF
hydroxylation reaction.
Yucel and
Kurnaz, 2007
Sensitivity of the
angiogenic behaviour
of a cancer cell to PHD
and FIH.
(1) The angiogenic potential of a
cancer cell is dependent on
HIF-mediated VEGF expression
which is differentially regulated
by FIH and PHD;
Both PHD and FIH overexpression in
hypoxia are predicted to decrease
HIF-mediated transcriptional activation
of VEGF. Only PHD is able to decrease
the transcriptional activity to normoxic
levels.
Concentrations of reaction
species and kinetic reaction
constants were inputted into
GEPASI alongside with the
governing equations following
the principle of Mass action and
Michealis-Menten kinetics.
Experimental or estimated
from the model followed
sensitivity analysis.
(2) Compartmentalisation (nuclear,
cytoplasmic and extracellular matrix)
is included for HIF and VEGF, but not
for the hydroxylases;
(3) FIH is a post-translational modificator
of HIF, through Asn-hydroxylation, which
sequesters HIF in a form that is unable to
bind the co-activators p300/CBP after
translocating into the nucleus.
(4) PHD is the regulator of HIF stability
by promoting the proteasome-mediated
degradation after the Pro-hydroxylation
of HIF.
Dayan et al.
2009
FIH controls a switch
between C-TAD and
N-TAD HIF target gene
repertoires
(1) The C-TAD modified by FIH and the
N-TAD modified by PHD function as
independent RNA polymerase recruitment
domains, controlling different subsets of
genes;
N-TAD dominant genes are predicted
to be induced during moderate hypoxia
while C-TAD dominant genes are
predicted to be induced in more severe
hypoxia, when FIH loses its activity.
Standard ODE approach, HIF
transcriptional activity is
modelled as a gene induction
function. This incorporates a
parameter “q” where q=0 for
Numerical fitting of the
parameters to experimental
data was done through
non-linear fitting with
Mathematica.
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Table 1 Summary of the main features of HIF models (Continued)
FIH-independent and q>0
for FIH-dependent genes.
(2) No assumption of a switch-like
behaviour;
The FIH sensitivity of a gene is proposed
to be estimated from the ratio of mRNA
fold change at 3% O2 and at anoxia.
(3) Only HIF-1α is modelled, and the data
is fitted to a HIF-1α only cell line (LS174).
No switch-like behaviour is predicted: the
model did not find a region in the
parameter space (k-space) where two
stable equilibriums could exist.
Schmierer et al.,
2010
ARD proteins
sequestration of FIH
modulates FIH activity
Building on the framework from
Dayan et al. (2007), the module was
extended at the conceptual level
into taking into consideration:
The FIH/ARD interaction is predicted to
provide a mechanism by which the
hypoxic response threshold can be:
Standard ODE approach was
used to modulate the HIF
transcriptional activity and
protein stability under
different combination of
hydroxylation status.
Numerical fitting of the
parameters to experimental
data was done through
non-linear fitting with
Mathematica.
(1) Asn-OH-C-TAD-HIF can lead to a third
subset of HIF target genes, which is only
activated in moderate hypoxia;
(i) varied (range finding mechanism);
(ii) ultrasensitive to oxygen level;
All simulation were done using
the open source software XPP-AUT.
(2) ARD proteins can sequester FIH in an
inactive state, until it is released at
intermediate oxygen concentrations
(moderate hypoxia)
(iii) sharpen the signal to response
curves;
Steady state values calculated by
running time course simulation at
different oxygen levels until a
steady state was achieved.
(3) HIF-1β, 2OG and Fe2+ are not limiting; (iv) create a time delay for C-TAD
hydroxylation upon reoxygenation
(memory effect).(4) Degradation of HIF-Pro-OH and HIF-α:
HRE binding are fast compared to Pro-
hydroxylation.
Nguyen,
Cavadas et al.,
2013
Global temporal
dynamics of the
HIF: PHD: FIH network.
(1) The degradation of Pro-OH HIF
via VHL binding is assumed to be
an irreversible step;
The model predictions match in-house
experimental data. The main findings are:
HIFα protein stabilisation and
activity and protein level for
PHD and FIH are modelled by
numerically integrating a system
of ODEs in different experimental
conditions (such as oxygen
concentration, PHD or PHD and
FIH inhibition) over 12 hours
period. This follows an iterative
process of predictive hypothesis
and experimental validation.
Numerical fitting of the
parameters to in-house
experimental data was done
through non-linear fitting
with Mathematica.(2) A generic PHD entity is considered
for simplicity;
(i) a residual activity of FIH at low oxygen
concentration which can be inhibited
by siRNA;
(3) FIH is assumed to be mostly
cytoplasmic;
(ii) HIF activity is not directly correlated
to HIF protein expression levels;
(4) Hydroxylation and VHL-mediated
degradation can occur in both nucleus
and cytoplasm with similar kinetics;
(iii) silencing FIH under conditions of
PHD inhibition increases HIF activity
but paradoxically reduces HIF stability,
explained by a role for FIH in controlling
HIF protein stability.(5) Asn-OH-HIF can be hydroxylated by
PHD but Pro-OH-HIF cannot be
hydroxylated by FIH due to the fast
degradation kinetics of Pro-OH-HIF;
(6) Hydroxylation steps are mostly
irreversible, although a small fraction
could in theory be reversible;
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Table 1 Summary of the main features of HIF models (Continued)
(7) Both hydroxylated and non-
hydroxylated HIF and PHD can shuttle
between the cytoplasm and the nucleus;
(8) p300/CBP co-activators are not
included and HIF-α/β dimer is assumed
to be active;
(9) PHD is HIF-inducible, forming
a negative feedback loop;
(10) Only nuclear HIF-α free of asparaginyl
hydroxylation is assumed to be
transcriptionally active.
* HIF is exported to the cytoplasm to undergo degradation upon reoxygenation of hypoxic cells [34,35].
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Figure 3 Different model-based explanations for the switch-like behaviour. (A) Hypoxia causes the oxygen-dependent HIF degradation rate
(Kdeg) via PHD and VHL to be lower than the oxygen-independent HIF synthesis rate (K0) [23]. (B) Hypoxia causes the oxygen-dependent HIF
degradation pathway (Flux 1) via PHD and VHL to be lower than the oxygen-independent pathway (Flux 2) [26]. (C) Oxygen regulates the activity
of PHD as well as the HIF nuclear export and the dissociation rates for HIF: HRE and HIF-1α/1β complexes [33].
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http://www.biosignaling.com/content/11/1/42hydroxylation reaction [38,40-42]. The prediction from
this model is that a high succinate to PHD ratio at the
beginning will result in a decrease in HIF-α hydroxylation
and increase in HIF activity (Figure 4C). This is relevant
to the condition when succinate level is higher than
normal, such as in the case of succinate dehydrogenase
deficiency [41,42].
Role of FIH in shaping the HIF response
The HIF-α protein contains two independent transcrip-
tional activation domains (N-TAD and C-TAD [43-46]).
PHD enzymes hydroxylates HIF-α at prolyl residues
present in the N-TAD, while FIH hydroxylates at the
asparaginyl residue in the C-TAD (Figure 5A). This is
mathematically represented in a model by Dayan and
colleagues, which aims to simulate the sensitivity of a set
of genes to FIH activity over an oxygen gradient [29]
(Figure 5A). Some genes are proposed to be dependent on
the N-TAD only, while others require an additional intact
non-asparaginylated C-TAD. Given that PHD has a higher
affinity for oxygen than FIH [47], the differential and
spatially dependent gene upregulation by HIF is attributed
to the sensitivity of certain genes to an oxygen gradient
which inactivates PHD but not FIH (mild hypoxia;
N-TAD-sensitive/C-TAD-insensitive genes) or both PHDand FIH (strong hypoxia; N-TAD/C-TAD-sensitive genes)
[29,46] (Figure 5A). This model prediction appears to
agree with experimental data on FIH-sensitive and
insensitive genes [46]. However, a group of other genes
(including BNIP3 - BCL2/adenovirus E1B 19 kD interacting
protein 3) does not fit the model, and FIH overexpression
instead increases their expression. For this observation,
Dayan and colleagues propose the existence of an unknown
C-TAD-dependent repressor which is activated and
de-represses this particular group of genes. Schmierer
and colleagues suggest an alternative explanation
based on their model, which predicts that a group of
genes (such as BNIP3) is actually activated by an
Asn-hydroxylated-C-TAD HIF-α, and thus not dependent
on CBP/p300 [27]. Schmierer’s model also includes the
hydroxylation of other ARD (ankyrin repeat domains)
proteins by FIH and assumes that there is competition
between ARD proteins and HIF for FIH (Figure 5B). Thus,
as oxygen tension decreases, the model predicts that FIH
catalytic activity decreases and is less likely to hydroxylate
HIF at its C-TAD [27]. Furthermore, Schmierer’s model of
ARD/HIF/FIH interactions is predicted to generate a time
delay for C-TAD hydroxylation and encode a memory
effect of the hypoxic episode [27]. The more severe the
hypoxic exposure, the longer will it take for FIH to be free
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Figure 4 Different model-based explanations for the effect of the PHD hydroxylation reaction on the HIF response. (A) The PHD
hydroxylation of HIF-1α protein requires molecular oxygen (O2), iron (Fe2+), 2-oxoglutarate (2OG) and ascorbate (Asc) as reactants, producing
succinate (Suc) and carbon dioxide (CO2). (B) In the presence of abundant PHD and hydroxylation cofactors, there is a step decrease in prolyl-
hydroxylated HIF (HIF-1α-POH) with decreasing oxygen. However, this decrease is linear under limited PHD2 or cofactors [25]. (C) Increasing the ratio
of succinate to PHD leads to increased succinate inhibition of PHD from negative feedback (A), resulting in decreased prolyl-hydroxylated HIF [28].
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http://www.biosignaling.com/content/11/1/42from ARD sequestration upon re-oxygenation, resulting in
non-Asn-hydroxylated C-TAD-HIF moiety lingering longer
in the nucleus.
The model developed in our lab considers the HIF-α
network as a dynamic system affected by both oxygen
concentration and the duration of exposure to hypoxia
[31]. The HIF-α moieties (free, prolyl- and asparaginyl-
hydroxylated forms) are treated and described separately in
the model, as are their cytoplasmic/nuclear localisation
(MIM shown in Figure 2). This model incorporates both
PHD and FIH as the major HIF hydroxylases and also
accounts for the negative feedback regulation due to
HIF-induced expression of PHD. Model calibration is
carried out based on experimental data generated in-house
which consist primarily of the time-course dynamic
data up to 12h post hypoxic stimulation of HIF stabilisation
and transcriptional activity using a pan-hydroxylase
inhibitor (Dimethyloxalylglycine, DMOG) or a selective
PHD-inhibitor (JNJ1935 [48]). The model is able to satisfac-
torily simulate the HIF-1α temporal response to different
oxygen levels and also to increasing concentrations of
DMOG and JNJ1935 (reflecting PHD+FIH or PHD
inhibition). It is also able to simulate the modest
effect of FIH silencing on HIF-1α activity observed
in vivo in mice lacking FIH [49]. Moreover, the model
predicts an unusual role for FIH in regulating the
stability of HIF by protecting HIF-1α from non-PHD
mediated degradation (Figure 5C). This prediction is
further supported by quantitatively analysis of a
reduced model containing core interaction module of theHIF network, and closely matches experimental data
using an overexpressed HIF-1α with mutated prolyl
residues (making it non-hydroxylable by PHD). Thus
this model reassures the known wiring structure of
the HIF network and more importantly a new role
for FIH in regulating HIF stability is proposed from
the model and validated experimentally.
Temporal dynamics of the HIF response to hypoxia
The transient accumulation of HIF-α during hypoxic
time-course exposure is a well characterised feature of
in vitro systems, described to be due to the presence of
negative feedback loops [25,28,30,31,50]. The best
described mechanism for this decrease is the up-regulation
of HIF-regulated PHD 2 and 3 enzymes [19,20], although
other HIF-regulated feedback such as mir-155 [50] can also
affect the transient response. Qutub and Popel analyse the
effect of varying the ratio of PHD: HIF synthesis and
predict that this might be a mechanism to generate
very different HIF responses, possibly to allow different
cell types to respond differently to a hypoxia stimulus
[28]. At higher PHD: HIF synthesis ratio, the HIF
response is sharp and transient. When the ratio is
lower, the response is delayed but does not attenuate, in
close agreement to experimental data in HEK293
cells [51]. Their model assumes that the PHD: HIF
synthesis ratio can be controlled by 3 feedback loops:
autocrine HIF up-regulation, negative feedback through
HIF up-regulation of PHD2 and succinate production
inhibition [28].
Pro-O
H
HIF-1
O2
FIH ARD
HIF-
FIH PHD 
Pro-O
H
A
sn-O
H
FIH PHD 
FIH PHD 
O2
No genes activated
N-TAD genes only
N-TAD and C-TAD 
genes
A 
B 
HIF-1
O2
PHD O2FIH 
C PHD-dependent 
degradation 
PHD-independent 
degradation 
Figure 5 New roles for FIH in the regulation of the HIF
response. (A) The HIF-α protein contains two independent
transcriptional activation domain (N-TAD and C-TAD), the N-TAD
overlaps with the CODDD. PHD enzymes hydroxylate the prolyl
residue present in the N-TAD, while FIH hydroxylates the asparaginyl
residue in the C-TAD. In high oxygen concentration, both PHD and
FIH are active, resulting in no HIF-regulated genes activated. As the
oxygen tension decreases, PHD is inactivated, resulting in expression
of N-TAD-sensitive genes. In strong hypoxia, both PHD and FIH are
inactivated, resulting in expression of N-TAD and C-TAD-sensitive
genes [29]. (B) FIH can hydroxylate either ARD or HIF-α proteins.
Sequestration of FIH by ARD inhibits HIF asparaginyl hydroxylation
[27]. (C) HIF-α can be degraded via either PHD-dependent or -
independent pathways. FIH hydroxylation of HIF is proposed to
protect HIF degradation via the PHD-independent pathway [31].
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Usefulness of current models
While many of the molecular components of the HIF
pathway have been identified and characterised, the
dynamics of their interaction within the network are less
well understood. Knowledge of the network components
alone do not warrant a wholistic understanding of the
system, particularly by simple intuition. The collection
of models developed so far for the HIF pathway has
provided different quantitative frameworks upon which
emergent properties of the network as a whole can be
obtained, which is crucially important in understanding
effects to perturbation such as drug responses. Some ofthese models provide plausible mechanistic explanations
for previously observed experimental observations which
are nontrivial otherwise. For example, the molecular
mechanisms leading to a HIF switch-like response to
decreasing oxygen levels have been extensively modelled
[23,26,33] based on the original experiments by Jiang
and co-workers [32]. These in silico studies can help in
the elucidation of the pathophysiological role of the oxygen
gradient established in a tumour microenvironment.
Furthermore, modelling and simulation can suggest new
testable hypotheses which guide further experiments in a
rational way. The model from Dayan and co-workers [29]
proposed a new paradigm of hypoxic differential gene
regulation within this tumour oxygen gradient. Given the
differences in oxygen sensitivity for PHD and FIH, a
sequential inhibition of PHD followed by FIH is predicted
down the oxygen gradient. Thus hypoxia is proposed to
induce specific HIF-regulated genes in a spatially controlled
way depending on their C-TAD or N-TAD sensitivities
[29]. It is normally assumed that HIF protein stabilisation is
indicative of HIF transcriptional activity. However, work
from our combined experimental and modelling study
shows that this is not necessarily true, and HIF activity is
tightly controlled by the activity of the asparaginyl
hydroxylase FIH [31]. Furthermore, our mathematical
model predicts that FIH, through asparaginyl-hydroxylation,
can protect HIF from PHD-independent degradation
mechanisms (Figure 5C), establishing a new role for
FIH in HIF stabilisation.
Limitations of the current models
The models developed so far have focused on understand-
ing the relationship among oxygen levels, a limited number
of micro environmental factors and the HIF response
(protein stability and transcriptional activity) using the
canonical components of the HIF pathway (HIF, VHL,
PHD, FIH and the HRE element). While the main
components can broadly describe the HIF response,
several assumptions have been made while constructing
the models. Sometimes these assumptions were taken to
simplify the modelling process but more often than not
the assumptions are due to lack of experimental data.
Indeed, most of the HIF models to date have been
constructed based on published third party data although
some models including ours [29,31] have benefited from a
process of iterative experimental and mathematical
validations. Moreover, the limitation in the availability
of dynamic experimental data has restricted most
models to focus on steady-state behaviour, except the
more recent ones [31].
A common assumption has been that the PHD
isoforms 1, 2 and 3 behave as a single entity, i.e. they
respond similarly to oxygen levels, are responsible for
maintaining the HIF baseline normoxic levels and are
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Although the oxygen sensitivities of the PHD enzymes
are generally similar [47], the PHD2 isoform is, for many
cell lines, the most abundant and considered to be the
main prolyl-hydroxylase for HIF stabilisation in normoxia
[52]. Experimentally however, the other two isoforms are
not redundant, as PHD1 and PHD3 have been shown to
contribute to the HIF regulation in certain cell lines [53].
Furthermore, compartmentalisation of the proteins
involved in the HIF response was rarely considered in
most models, even though PHDs were shown to have
specific localisation in the cell which could affect their
activities [54]. Similarly, HIFα exists as three different
subunits (1, 2 and 3) and have been shown to regulate
specific sets of genes [55,56]. While it is technically
possible to differentiate among the subunits through
isoforms specific gene silencing, most mathematical
models simply assume that hypoxia response is mediated
by HIF-1α only. Our group has bypassed this challenge by
modelling the hypoxia response in HEK293 cells lacking
the HIF-2α subunit [31].
The lack of signalling crosstalks in the current models
reflects the technical challenges to obtain high quality
data on the dynamics of different transcriptional factor
activities (such as for HIF with NFκB) and to measure
the abundance/modification states of signalling proteins.
Fortunately, there have been recent advances which have
facilitated the generation of quantitative experimental
data suitable for mathematical modelling. For example,
the simultaneous transfer of proteins from multiple
gel-strips onto the same membrane (multi-strip western
blot) has increased data output per single blotting cycle
and allowed simultaneous monitoring of proteins while
reducing signal errors [57,58]. Also, our group has initiated
the use of secreted luciferases as a non-invasive method
for monitoring the temporal dynamics of transcriptional
activity [31,59,60].
Opportunities for future modelling work
Overall, most of the modelling effort up to date has been
centred on the in vitro HIF response to hypoxia with the
HIF pathway being the sole focus (Figure 6). However,
HIF is known to have important roles in normoxia, and
more complex physiological conditions governed by
extensive crosstalk to other pathways. Interestingly, but
perhaps not surprisingly due to the increased complexity
of the system, mathematical modelling of the crosstalk
and synergism with other pathways such as NFκB
[60,61] and mTOR [39,62,63] have not been considered.
We will focus on NFκB and mTOR as examples of
topics for further research due to their significant degree
of crosstalk during two pathophysiological conditions of
both basic and pharmacological interests: inflammation
and cancer.HIF and NFκB crosstalk during hypoxic inflammation
Sites of chronic inflammation including arthritic joints
and inflamed intestinal mucosa demonstrate decreased
oxygen availability [61,64,65]. This is likely caused by
increased oxygen demand from the inflamed tissue [66]
as well as from the vasculopathy that leads to reduced
blood perfusion [67,68]. In this context both HIF and
NFκB seem to play important functions. HIF can have
both pro-inflammatory and anti-inflammatory roles,
dependent on the cell where it is expressed, while
NFκB works primarily as regulator of inflammatory
and anti-apoptotic gene expression [69]. In this hypoxic
inflammation context, HIF and NFκB seem to share
sensitivity to similar stimulus. HIF is affected by reactive
oxygen species ROS from the oxidative burst [70] and can
be independently activated by hypoxia at the protein level
and by bacterial lipopolysaccharide, tumour necrosis
factor α, and interleukin-18 [70-74] in a mechanism
involving the NFκB pathway. Furthermore, NFκB has also
been reported to play a role in hypoxia-induced HIF-1α
mRNA expression [71] and in keeping basal levels of
HIF-1α gene expression [72,75]. Converserly, NFκB
has also been shown to be regulated by hypoxia and
hypoxic mimetics [76,77], several components of the
NFκB pathway are hydroxylated by prolyl and asaparaginyl
hydroxylases [78], and there is also compelling evidence for
a role of HIF in the regulation of NFκ signalling [69,79,80],
these two transcription factors seem to be able to integrate
similar stimulus and to have an extensive crosstalk in
the regulation of several inflammatory genes including
cyclooxygenase 2 [60,81] and IL-1β [82]. Further under-
standing of this crosstalk with the help of mathematical
modelling can provide a better understanding of gene
regulation in hypoxic inflammation (Figure 6).
HIF and mTOR crosstalk in cancer
In the complex process of cancer development, cells need
to accumulate mutations that allow them to escape the
intrinsic cellular and extrinsic environmental constraints
on proliferation [83]. Solid tumors, where the process of
tumor expansion exceeds the development of blood
vessels, associated with the fact that the new blood vessels
are aberrant and have poor blood flow [84], results in a
hypoxic tumour microenvironment. Processes regulated
by hypoxia in cancer extend from angiogenesis, glycolysis
and growth-factor signalling to immortalisation, genetic
instability, tissue invasion, metastasis, apoptosis and pH
regulation. Most of the hypoxia-induced pathways pro-
mote tumour growth, but apoptosis is also induced by
hypoxia. HIF-1α and HIF-2α protein is overexpressed in
several primary tumours and this is associated with
increased patient mortality, indicating that the HIF path-
way promotes oncogenesis and/or cancer progression [1].
The balance of these pathways might be critical for the
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Importantly, mTOR transcriptionally regulates HIF in response to growth factors (13) and HIF regulates for growth factor receptors and adaptor
proteins which can affect mTOR signalling (14). While most of the mechanisms of the effect of cellular hypoxia on the HIF response have been
modelled (15, continuous lines), the HIF/hypoxia crosstalk to NFκB and mTOR and the outcome of the interaction of these pathways in
inflammation and tumour development are still open opportunities for further modelling research (16,17, dashed lines).
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http://www.biosignaling.com/content/11/1/42effects of hypoxia on tumour growth [1,84]. The
mammalian target of rapamycin (mTOR) is a highly
conserved kinase which can integrates signals from
nutrients (amino acids and energy) and growth factors
(in higher eukaryotes) to regulate cell growth and cell
progression co-ordinately [85]. Its classical targets being
the ribosomal p70S6 kinase (p70S6K) and eIF4E-binding
protein, which lead to enhancement of translation and
transcription, enabling cell growth and cell cycle progres-
sion from G1 to S phase. Pathways upstream of mTOR
and mTOR themselves are activated in cancer. Insulin,angiotensin-II and epidermal growth factor have been
shown to up-regulate HIF in the presence of molecular
oxygen [62,86,87] and mTOR inhibition decreases tumour
progression partially to decreased neo-vascularisation
[88], indicating mTOR as a regulator of HIF by increasing
its mRNA translation. Conversely mTOR signalling can
also be affected by HIF and hypoxia, HIF target genes
involved in cell proliferation and viability (insulin-like
growth factor receptor-2 and insulin-like growth factor
receptor binding protein-1, [86]) can further amplify
mTOR signalling, and hypoxia can directly impact on
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http://www.biosignaling.com/content/11/1/42mTOR signalling at multiple points [63], in a mechanism
where the crosstalk between two pathways can potentiate
cancer development (Figure 6). Mathematical modelling
of these crosstalks is expected to provide important hints
on the key therapeutic target nodes that could disrupt cell
proliferation.
Conclusions
Most of the modelling studies on the HIF pathway have
been concerned with the core components of the
pathway: HIF, PHD, FIH and VHL, which seem to suffice
in providing the system with the characteristic network
features: switch-like behaviour and attenuation under
prolonged hypoxia. This supports the view that essential
behaviour of biological systems is often encoded within
small “core” subsystems, while additional complexity
may serve to fine tune this behaviour. The additional
complexity can be encoded by changes in the molecular
microenvironment [25,28,38,40-42] and brought about
by feedback loops [25,28,30,31,50].
While all models are supposedly wrong, some are
useful [89]. This apparent limitation, though, has a
positive implication: failure of a model to reproduce
experimental data often indicate the presence of
additional elements and prompt further investigations
into the regulatory mechanisms of that same system.
Mathematical modelling is therefore a valuable tool in
aiding experimental biologists to better understand the
HIF pathway by providing explanations for complex and
sometimes counter-intuitive behaviours and offering
predictions on missing protein partners or unknown
functional relationships between components. Furthermore,
modelling of the HIF response in more complex biological
settings such as cancer and inflammation, where HIF is
known to interact with major signalling pathways activated
in these contexts, will facilitate biologists in formulating
new hypothesis to explain complex behaviours.
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